Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2006-11-14
2006-11-14
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S185100, C424S190100, C424S192100, C424S234100, C435S004000, C435S007100, C435S007200, C435S007320, C436S501000, C530S300000, C530S350000, C536S023400, C536S023700
Reexamination Certificate
active
07135176
ABSTRACT:
The present invention relates to DNA sequences encoding Vmp-like polypeptides of pathogenicBorrelia, the use of the DNA sequences in recombinant vectors to express polypeptides, the encoded amino acid sequences, application of the DNA and amino acid sequences to the production of polypeptides as antigens for immunoprophylaxis, immunotherapy, and immunodiagnosis. Also disclosed are the use of the nucleic acid sequences as probes or primers for the detection of organisms causing Lyme disease, relapsing fever, or related disorders, and kits designed to facilitate methods of using the described polypeptides, DNA segments and antibodies.
REFERENCES:
patent: 4801540 (1989-01-01), Hiatt et al.
patent: 5155022 (1992-10-01), Naqui et al.
patent: 5178859 (1993-01-01), Simon et al.
patent: 5187065 (1993-02-01), Schutzer
patent: 5217872 (1993-06-01), Dorward et al.
patent: 5217874 (1993-06-01), Guadagno et al.
patent: 5246844 (1993-09-01), Norris et al.
patent: 5279938 (1994-01-01), Rosa
patent: 5283175 (1994-02-01), Weaver et al.
patent: 5304718 (1994-04-01), Ward et al.
patent: 5324630 (1994-06-01), LeFebvre et al.
patent: 5385826 (1995-01-01), Schell et al.
patent: 5434077 (1995-07-01), Simon et al.
patent: 5436000 (1995-07-01), Barbour et al.
patent: 5571718 (1996-11-01), Dunn et al.
patent: 6475492 (2002-11-01), Philipp et al.
patent: 6610301 (2003-08-01), Motz et al.
patent: 6660274 (2003-12-01), Philipp
patent: WO 91/13630 (1991-09-01), None
patent: WO 00/65064 (2000-11-01), None
Balmelii and Piffatetti, “Analysis of the genetic polymorphism ofBorrelia burgdorferisensu lato by multilocus enzyme electrophoresis,”Int. J. Syst. Bacteriol., 46:167-172, 1996.
Barbour and Garon, “Linear plasmids of the bacteriumBorrelia burdorferihave covalently closed ends,”Science, 237:409-411, 1987.
Barbour et al., “Structural analysis of the variable major proteins ofBorrelia hermsii,” J. Exp. Med., 158:2127-2140, 1983.
Barbour et al., “Tandem insertion sequence-like elements define the expression site for variable antigen genes ofBorrelia hermsii,” Infect. Immun., 59:390-397, 1991.
Barbour et al., “Variable antigen genes of the relapsing fever agentBorrelia hermsiiare activated by promoter addition,”Mol. Microbiol., 5:489-493, 1991.
Barbour et al., “Variable major proteins ofBorrelia hermsii,” J. Exp. Med., 156:1312-1324, 1982.
Barbour, “Immunochemical analysis of Lyme disease spirochetes,”Yale J. Biomed., 57:581-586, 1984.
Barbour, “Plasmid analysis ofBorrelia burgdorferi, the Lyme disease agent,”J. Clin Microbiol., 26(3):475-478, 1988.
Barstad et al., “Variable major proteins ofBorrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides,”J. Exp. Med., 161:1302-1314, 1985.
Benach et al., “A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the lyme disease spirochete,”The Journal of Immunology, 140:265-272, 1988.
Berg et al., “The laboratory diagnosis of lyme disease,”Arch. Dermatol., 127:866-870, 1991.
Borenstein et al., “Evidence for surface exposure of a 29kDaBorrelia burgdorferiantigen,”Abstracts of the Annual Meeting of American Soc. Microbiol., 90(0):46, Abstract B-116, 1990.
Brandt et al., “Immunogenic integral membrane proteins ofBorrelia burgdorferiare lipoproteins,”Infect. Immun., 58(4):983-991, 1990.
Burman et al., “The variable antigens Vmp7 and Vmp21 of the relapsing fever bacteriumBorrelia hermsiiare structurally analogous to the VSG proteins of the African trypanosome,”Molecular Mocrobiology, 4(10);1715-1726, 1990.
Carroll and Gheradini, “Membrane protein variations associated within vitropassage ofBorrelia burgdorferi,” Infect. Immun., 64:392-398, 1996.
Carter et al., “A family of surface-exposed proteins of 20 kilodaltons in the genusBorrelia,” Infect. Immun., 62:2792-2799, 1994.
Casjens et al., “Linear chromosomes of Lyme disease agent spirochetes: genetic diversity and conservation of gene order,”J. Bacteriol., 177:2769-2780, 1995.
Cluss and Boothby, “Thermoregulation of protein synthesis inBorrelia burgdorferi,” Infect. Immun., 58(4):1038-1042, 1990.
Cunningham et al.,Ann. NY Acad. Sci, 539:376-378, 1988.
Dialog Search Report.
Donelson, “Mechanisms of antigenic variation inBorrelia hermsiiand African trypanosomes,”J. Biol. Chem., 270:7783-7786, 1995.
Fawcett et al., “Detetion of antibodies to the recombinant p39 protein ofBorrelia burgdorferiusing enzyme immunoassay and immunoblotting,”J. Rheumatology, 20(4):734-738, 1993.
GenBank Accession No. AAB09432.
GenBank Accession No. AAB17737.
GenBank Accession No. AAC45733.
Grodzicki and Steere, “Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early lyme disease,”J. Infect. Dis., 157(4):790-797, 1988.
Howe et al., “A single recombinant plasmid expressing two major outer surface proteins of the lyme disease spirochete,”Science, 227:645-646, 1985.
Howe et al., “Organization of genes encoding two outer membrane proteins of the lyme disease agentBorrelia burgdorferiwithin a single transcriptional unit,”Infect. Immun., 54:207-212, 1986.
Hyde et al., “Detection of antigens in urine of mice and humans infected withBorrelia burgdorferi, etiologic agent of lyme disease,”Journal of Clinical Microbiology, 27(1):58-61, 1989.
International Search Report dated Jan. 21, 1995.(PCT/US94/10729) (UTFH:195P).
International Search Report dated Jan. 26, 1993.(PCT/US92/09145) (UTFH:162P).
International Search Report dated Jul. 25, 1997 (PCT/US97/02952) (UTFH:234P).
Jiang et al., “Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins ofBorrelia burgdorferi,” J. Immun., 144(1):284-289, 1990.
Kalish, “Lyme Disease,”Infect. Arthritis, 19(2):399-426, 1993.
Karlsson, “Western immunoblot and flagellum enzyme-linked immunosorbent assay for serodiagnosis of lyme borreliosis,”J. Clin. Microbiol., 28(9):2148-2150, 1990.
Kitten and Barbour, “Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacteriumBorrelia hermsii,” Proc. Natl. Acad. Sci. USA, 87:6077-6081, 1990.
Kitten et al., “Intragenic recombination and a chimeric outer membrane protein in the relapsing fever agentBorrelia hermsii,” J. Bacteriol., 175(9):2516-2522, 1993.
LeFebvre et al., “Characterization ofBorrelia burgdorferiisolates by restriction endonuclease analysis and DNA hybridization,”Journal of Clinical Microbiology, 27(4):636-639, 1989.
Liang et al., “An immunodominant conserved region within the variable domain of VIsE, the variable surface antigen ofBorrelia burgdorferi,” J. Immunology, 163:5566-5573, 1999.
Liang et al., “Characterization of aBorrelia burgdorferiVIsE invariable region useful in canine lyme disease serodiagnosis by enzyme-linked immunosorbent assay,”J. Clinical Microbiology, 38(11):4160-4166, 2000.
Liang et al., “Sensitive and specific serodiagnosis of lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region ofBorrelia burgdorferiVIsE,”J. Clinical Microbiology, 37(12):3990-3996, 1999.
Luft et al., Biochemical and immunological characterization of the surface proteins ofBorrelia burgdorferi, Infect. Immun., 57(11):3637-3645, 1989.
Margolis et al., “Homology betweenBorrelia burgdorferiOspC and members of the family ofBorrelia hermsiivariable major proteins,”Gene, 143:105-110, 1994.
Moody et al., “Lyme borreliosis in laboratory animals: effect of host species andin vitropassage ofBorrelia burgdorferi,” Am. J. Trop. Med. Hyg., 43(1):87-92, 1990.
Norris et al., “Comparison of protein and fatty acid profiles of
Barbour Alan G.
Hardham John M.
Howell Jerrilyn K.
Norris Steven J.
Weinstock George M.
Board of Regents , The University of Texas System
Fulbright & Jaworski
Swartz Rodney P
LandOfFree
VMP-like sequences of pathogenic Borrelia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VMP-like sequences of pathogenic Borrelia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VMP-like sequences of pathogenic Borrelia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3676181